Dystonia Drugs Market to reach USD 15.1 Mn by 2029 at a growth rate of 6.8 percent over the forecast period

Pune, May 08, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, a global Healthcare market research firm has published competitive intelligence and market research report on the "Dystonia Drugs Market". The Dystonia Drugs Market size was valued at USD 9.5 Mn in 2022. The total Dystonia Drugs Market revenue is expected to grow at a CAGR of 6.8 percent from 2022 to 2029, reaching USD 15.1 Mn during the forecast period.

Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/186231

Dystonia Drugs Market Scope and Research Methodology

The report includes a detailed analysis of the Dystonia Drugs Market. The competitive analysis in the report includes a company overview, financial performance, product portfolio, and strategies of the key players in the Dystonia Drugs industry. Key insights provided in the report are the major drivers of the Dystonia Drugs Market, the challenges faced by the market participants, and growth prospects in the Dystonia Drugs Market across the world. The Dystonia Drugs Market report covers a detailed analysis of the investments of market players to increase their global presence in the industry, which makes it an investor's guide.

The segments covered in the report are Drug Type, Route of Administration and Distribution Channel. Primary and Secondary research method was used to collect data for the Dystonia Drugs market report. Primary research was conducted to validate the findings from the secondary research method. The Dystonia Drugs size was estimated by using a bottom-up approach.

Dystonia Drugs Market Overview

Dystonia is a neurological movement disorder that cause twisting, repetitive movements, or abnormal postures. There is no cure for Dystonia, but are treatment available to treat and manage symptoms, including medications. Increasing prevalence of dystonia and related disorders is expected to boost the Dystonia Drugs Market growth.

Get a Sample Copy of the Report : https://www.maximizemarketresearch.com/request-sample/186231

Rising prevalence of neurological disorders is expected to boost the Dystonia Drugs Market growth

Dystonia is most common neurological disorders, affecting approximately 1% of the population. Growing prevalence of neurological disorders, including dystonia, is expected to boost the demand for effective treatments and influence the Dystonia Drugs Market growth. Increasing demand for effective treatments that can help manage symptoms and improve quality of life and is expected to boost the Dystonia Drugs Market growth.

High cost of dystonia drugs acting is expected to hamper the Dystonia Drugs Market growth. Growing prevalence of neurological disorders expected to present lucrative opportunities for the market growth.

North America region to boost the Dystonia Drugs Market growth over the forecast period

North America region dominated the Dystonia Drugs Market in 2022 and is expected to continue the dominance over the forecast period. High prevalence of dystonia in the region, with a large number of patients diagnosed with the condition, and a well-established healthcare infrastructure is expected to boost the Dystonia Drugs Market growth. Availability of advanced medical facilities and a strong focus on research and development activities significantly contribute for the market growth.

High healthcare spending, favourable regulatory environment, and rising awareness about neurological disorders is expected to boost the European region Dystonia Drugs Market growth.

Get Customization on this Report for Specific Research Solutions: https://www.maximizemarketresearch.com/request-customization/186231

Dystonia Drugs Market segmentation

By Drug Type:

• Anticonvulsants drugs
• Dopaminergic agents
• GABAergic agents
• Others

Based on Drug Type, the market is segmented into Anticonvulsants drugs, Dopaminergic agents, GABAergic agents and others. Anticonvulsants drugs segment dominated the Dystonia Drugs Market in 2022 and is expected to continue the dominance over the forecast period. Anticonvulsants are commonly used to treat dystonia, and reduce muscle contractions and improve motor function in patients and is expected to boost the Anticonvulsants drugs segment growth over the forecast period.

By Route of Administration:

• Oral
• Injectable

By Distribution Channel:

• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies
  

Dystonia Drugs Market Key Players key players include:

• Merz Pharma GmbH & Co. KGaA (Germany)
• Ipsen (France)
• Allergan plc (Ireland)
• US WorldMeds, LLC (United States)
• Valeant Pharmaceuticals (Canada)
• Revance Therapeutics, Inc. (United States)
• AbbVie Inc. (United States)
• Impel NeuroPharma (United States)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Galderma S.A. (Switzerland)
• Pfizer Inc. (United States)
• Mylan N.V. (Netherlands)
• H Lundbeck A/S (Denmark)
• Britannia Pharmaceuticals Ltd. (United Kingdom)
• Sun Pharmaceutical Industries Ltd. (India)
• Zambon S.p.A. (Italy)
• Retrophin Inc. (United States)
• Kyowa Kirin Co. Ltd. (Japan)
• Insys Therapeutics, Inc. (United States)
  

Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/186231

Key questions answered in the Dystonia Drugs Market are:

• What are Dystonia Drugs Market?
• What was the Dystonia Drugs market size in 2021?
• What is the expected Dystonia Drugs market size by 2029?
• What is the growth rate of the Dystonia Drugs Market?
• Which are the factors expected to drive the Dystonia Drugs market growth?
• Which segment dominated the Dystonia Drugs market growth?
• What is the demand pattern for the Dystonia Drugs market?
• Which region held the largest share in the Dystonia Drugs market?
• Who are the key players in the Dystonia Drugs market?
  

Key Offerings:

• Past Market Size and Competitive Landscape (2018 to 2021)
• Past Pricing and price curve by region (2018 to 2021)
• Market Size, Share, Size & Forecast by different segment | 2022−2029
• Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
• Market Segmentation – A detailed analysis by Drug Type, Route of Administration, and Distribution Channel
• Competitive Landscape – Profiles of selected key players by region from a strategic perspective
  • Competitive landscape – Market Leaders, Market Followers, Regional player
  • Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
• Legal Aspects of business by region
• Lucrative business opportunities with SWOT analysis
• Recommendations

Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Wilson Disease Drugs Market: The total market size was valued at USD 637.36 Mn in 2022 and the total Wilson Disease Drugs revenue is expected to grow by 4.4 percent from 2023 to 2029, reaching USD 861.6 Mn. Increasing awareness among the people for disease treatment and growing prevalence of chronic pain is expected to boost the market growth.

Breast Cancer Drug Market: The total market size was valued at USD 32.5 Bn in 2022 and the total Breast Cancer Drug revenue is expected to grow at a CAGR of 14.8 percent from 2023 to 2029, reaching USD 98.04 Bn. High prevalence of Breast Cancer amongst populations across the world is expected to boost the market growth.

Sarcoma Drugs Market: The total market size was valued at USD 759.2 Mn in 2021 and the total Sarcoma Drugs revenue is expected to grow by 23 percent from 2022 to 2029, reaching USD 1405.3 Mn. Growing use of immunotherapy for the treatment of sarcoma and Increasing Cancer Prevalence is expected to boost the market growth.

Pharmaceutical Drug Delivery Market: The total market size was valued at USD 1.9 Bn in 2021 and the total Pharmaceutical Drug Delivery revenue is expected to grow by 7 percent from 2022 to 2029, reaching USD 3.3 Bn. Increased patient shift towards advanced drug delivery systems and increasing burden of chronic diseases is expected to boost the market growth.

Cancer Supportive Care Drugs Market: The total market size was valued at USD 10.92 Bn in 2021 at growth rate of 5.7 percent reaching USD 17.02 Bn by 2029. Large number of adverse effects associated with cancer therapy, increasing penetration of biosimilars, rising healthcare expenditures is expected to boost the market growth.

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656